Rohto Pharmaceutical Hits Day Low Amid Price Pressure, Shares at JPY 2,356.00

Rohto Pharmaceutical Co., Ltd. experienced a significant decline today, with its stock price dropping by 5.06% to reach an intraday low of JPY 2,356.00. This performance stands in contrast to the Japan Nikkei 225, which saw a modest decrease of 0.58% on the same day.
Over the past week, Rohto's stock has decreased by 5.21%, while the Nikkei 225 has gained 1.83%. The one-month performance reflects a more pronounced decline of 7.72% for Rohto, compared to a 10.72% increase in the broader market index. Year-to-date, the stock has fallen by 18.12%, contrasting sharply with the Nikkei's 25.88% rise.

In terms of long-term performance, Rohto has faced challenges, with a 29.4% drop over the past year and a 28.28% decline over the last five years. Despite these setbacks, the company maintains a solid return on equity of 13.80% and a low debt-to-equity ratio of -0.10, indicating a strong financial position. The stock's price-to-earnings ratio stands at 14.00, reflecting its current valuation in the FMCG sector.